Cholesterol Management

An FDA advisory committee has voted to recommend approval of a new drug for the long-term treatment of patients with hypercholesterolemia and dyslipidemia.

Researchers studied the impact of replacing saturated fatty acids with unsaturated fatty acids on cholesterol.